These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6410211)

  • 1. [Dopaminergic ergot combinations. A new therapeutic principle].
    von Werder K
    MMW Munch Med Wochenschr; 1983 Jun; 125(23):489-91. PubMed ID: 6410211
    [No Abstract]   [Full Text] [Related]  

  • 2. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
    [No Abstract]   [Full Text] [Related]  

  • 3. DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S74-8. PubMed ID: 12211144
    [No Abstract]   [Full Text] [Related]  

  • 4. DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S79-82. PubMed ID: 12211145
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacology of ergot alkaloids in clinical use.
    Berde B
    Med J Aust; 1978 Nov; 2(3 Suppl):3-13. PubMed ID: 370528
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of ergot alkaloids on growth hormone and prolactin secretion in humans.
    Silvestrini F; Liuzzi A; Chiodini PG
    Pharmacology; 1978; 16 Suppl 1():78-87. PubMed ID: 643905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ergot drugs in the treatment of endocrine disorders: introduction.
    Kleinberg DL; Frantz AG
    Adv Biochem Psychopharmacol; 1980; 23():143-6. PubMed ID: 7395608
    [No Abstract]   [Full Text] [Related]  

  • 8. The inability of bromocriptine to inhibit prolactin secretion by transplantable rat pituitary tumors: observations on the mechanism and dynamics of the autofeedback regulation of prolactin secretion.
    Lamberts SW; MacLeod RM
    Endocrinology; 1979 Jan; 104(1):65-70. PubMed ID: 446356
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopaminephilic properties of ergot alkaloids.
    Goldstein M; Lew JY; Nakamura S; Battista AF; Lieberman A; Fuxe K
    Fed Proc; 1978 Jun; 37(8):2202-6. PubMed ID: 26607
    [No Abstract]   [Full Text] [Related]  

  • 10. Bromocriptine.
    McGregor AM
    Practitioner; 1981 Oct; 225(1360):1471-5. PubMed ID: 7329935
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analogue drugs of ergot-alkaloids with an inhibitory effect upon prolactin secretion and their influence upon the mammary gland (author's transl)].
    Rezábek K; Ausková M; Semonský M
    Cesk Gynekol; 1975 Feb; 40(1):52-3. PubMed ID: 1131904
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of the effects of four ergot derivatives on prolactin secretion by dispersed rat pituitary cells.
    Delitala G; Yeo T; Grossman A; Hathway NR; Besser GM
    J Endocrinol; 1980 Oct; 87(1):95-103. PubMed ID: 7430919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bromocriptine, ergotamine and other ergot alkaloids on the hormone secretion and growth of a rat pituitary tumour.
    Prysor-Jones RA; Jenkins JS
    J Endocrinol; 1980 Jul; 86(1):147-53. PubMed ID: 7430884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modern drug treatment of hyperprolactinemia].
    Rachev E; Spasov S
    Akush Ginekol (Sofiia); 1985; 24(6):81-4. PubMed ID: 3911788
    [No Abstract]   [Full Text] [Related]  

  • 15. Bromocriptine update.
    Borowski GD; Rose LI
    Am Fam Physician; 1984 Aug; 30(2):218-20. PubMed ID: 6464960
    [No Abstract]   [Full Text] [Related]  

  • 16. DA agonists -- ergot derivatives: dihydroergocryptine (DHEC): management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S72-3. PubMed ID: 12211143
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of lactation with a new ergot derivative, CB-154. Comparison with ablacton].
    Mendes ML
    Brux Med; 1974 Dec; 54(12):737-41. PubMed ID: 4474051
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of ergot alkaloids on the hypothalamic-pituitary axis.
    Flückiger E; Doepfner W; Markó M; Niederer W
    Postgrad Med J; 1976; 52suppl 1():57-63. PubMed ID: 959126
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of dopaminergic ergot derivatives with cyclic nucleotide system.
    Spano PF; Saiani L; Memo M; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 23():95-102. PubMed ID: 6249093
    [No Abstract]   [Full Text] [Related]  

  • 20. Bromocriptine and lisuride in Parkinson disease.
    Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
    Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.